We are live on ! Find out more
BNR icon

Burning Rock Biotech

16 hedge funds and large institutions have $27.4M invested in Burning Rock Biotech in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital inflows, than outflows

Capital inflows: $6.76M | Capital outflows: $6.52M

0% more funds holding

Funds holding: 16 → 16 (0)

0% more ownership

Funds ownership: 15.88% → 15.89% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
3
Increased
3
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BNR Hedge Fund Activity: Q1 2026 in Review

16 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q1 2026, worth a combined $27.4M — down 22% from $34.9M a quarter earlier.

Fund positioning in BNR was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 7 trimmed.

The largest buyer was Kynam Capital Management, adding an estimated $6.09M. The largest seller was CRCM LP, cutting an estimated $5.48M.

  • 16 institutional investors held Burning Rock Biotech (BNR) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $27.4M of Burning Rock Biotech stock for Q1 2026, down 22% quarter-over-quarter.
  • 3 funds opened new Burning Rock Biotech positions in Q1 2026 and 3 closed out, a net change of 0 holders.
  • The largest Burning Rock Biotech buyer in Q1 2026 was Kynam Capital Management, an estimated $6.09M added.
  • The largest Burning Rock Biotech seller in Q1 2026 was CRCM LP, an estimated $5.48M sold.

Based on aggregated 13F filings for Q1 2026.